Wholesale Suppliers for Medspas and Compound Pharmacies 👀
The Peptide Supply Chain Reality 💰 So here's what I've discovered about how research companies are making BANK selling to medspas and compound pharmacies... The Simple Business Model 📈 Research companies sell lyophilized (freeze-dried) peptides to medspas and compound pharmacies, who then turn around and charge patients massive markups. The Numbers: - Research company sells 10mg Semaglutide for ~$45-80 - Medspa/pharmacy charges patients $300-500+ for the same vial - That's a 400-600% markup 🤯 How It Works 🔄 1. Research Companies produce lyophilized peptides in bulk 2. Medspas/Compound Pharmacies buy wholesale (usually $50-150/vial depending on peptide) 3. End Customer gets charged $250-800+ for the exact same product 4. Everyone wins except the patient's wallet Popular Peptides & Markups 💉 Semaglutide (GLP-1): - Wholesale: $45-80 - Retail: $300-500 - Markup: 500%+ Tirzepatide: - Wholesale: $85-120 - Retail: $400-600 - Markup: 400-500% BPC-157: - Wholesale: $25-40 - Retail: $150-250 - Markup: 300-400% Why This Model Works 🎯 ✅ Medspas get consistent supply without pharma licensing hassles ✅ Compound pharmacies can offer "custom" formulations ✅ Research companies move volume at steady margins ✅ Patients think they're getting "premium compounded" products The Supply Chain 📦 Research Company → Medspa/Pharmacy → Patient The research companies handle: - Manufacturing/sourcing - Quality testing (COAs) - Bulk packaging - Wholesale distribution The medspas/pharmacies handle: - Customer acquisition - Medical consultations - Reconstitution/preparation - Premium pricing/branding Real Talk 💯 This is basically private labeling for the peptide world. Same product, different markup depending on where you buy it. The research companies are smart - they focus on volume and consistency rather than dealing with end consumers. Let the medspas handle customer service, marketing, and compliance headaches. Drop your experiences below - curious to see what pricing everyone else is seeing.